MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
83.53%
Quick Ratio
66.24%
Cash Ratio
25.58%
Debt to Asset Ratio
116.87%
Unit: Million (M) dollars
Assets Breakdown
Deferred tax assets
Accounts receivable, net of allo...
Cash and cash equivalents
Others
Liabilities Breakdown
Accrued rebates and product retu...
Long-term debt, less current por...
Accumulated deficit
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
222
175
195
445
Short-term investments
-
-
0
0
Accounts receivable, net of allowances of 3 (2026) and 4 (2025)
271
273
253
259
Inventories
150
152
153
155
Prepaid expenses
14
15
34
30
Current tax receivable
16
12
2
13
Other current assets
54
40
16
19
Total current assets
725
667
652
922
Long-term investments
27
27
28
28
Property, plant and equipment, net
162
157
144
124
Operating lease right of use assets, net
21
22
26
30
Goodwill and other intangible assets, net
2
2
2
-
Deferred tax assets
271
296
323
285
Other noncurrent assets
24
26
27
27
Total assets
1,233
1,197
1,201
1,416
Accrued rebates and product returns
610
551
582
613
Accounts payable and accrued expenses
206
178
250
215
Accrued litigation settlement expenses, current
14
14
42
106
Current portion of long-term debt
0
0
29
18
Operating lease liabilities, current
9
9
10
10
Income taxes payable
30
26
2
4
Other current liabilities
-
-
0
0
Total current liabilities
868
779
914
965
Long-term debt, less current portion
487
486
290
304
Accrued litigation settlement expenses, noncurrent
42
41
52
300
Operating lease liabilities, noncurrent
13
14
22
24
Other noncurrent liabilities
31
21
21
30
Total liabilities
1,441
1,341
1,300
1,623
Common stock, par value 0.50 per share issued shares 125 (2025) and 125 (2024)
-
-
62
62
Additional paid-in capital
155
165
112
109
Share repurchase commitment
-
-
0
0
Accumulated other comprehensive loss
-28
-29
-30
-32
Accumulated deficit
-334
-280
-243
-346
Total stockholders' deficit
-208
-144
-98
-207
Total liabilities and stockholders' deficit
1,233
1,197
1,201
1,416
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Accounts receivable, net
of allowances of 3...
$271M
(12.92%↑ Y/Y)
Cash and cash
equivalents
$222M
(-56.47%↓ Y/Y)
Inventories
$150M
(0.67%↑ Y/Y)
Other current assets
$54M
(170.00%↑ Y/Y)
Current tax receivable
$16M
(433.33%↑ Y/Y)
Prepaid expenses
$14M
(-50.00%↓ Y/Y)
Total current assets
$725M
(-23.76%↓ Y/Y)
Deferred tax assets
$271M
(0.37%↑ Y/Y)
Property, plant and
equipment, net
$162M
(38.46%↑ Y/Y)
Long-term investments
$27M
(0.00%↑ Y/Y)
Other noncurrent
assets
$24M
(-45.45%↓ Y/Y)
Operating lease right of
use assets, net
$21M
(-40.00%↓ Y/Y)
Goodwill and other
intangible assets, net
$2M
(-71.43%↓ Y/Y)
Total assets
$1,233M
(-15.08%↓ Y/Y)
Accumulated deficit
-$334M
(13.92%↑ Y/Y)
Accumulated other
comprehensive loss
-$28M
(15.15%↑ Y/Y)
Total liabilities and
stockholders' deficit
$1,233M
(-15.08%↓ Y/Y)
Total stockholders'
deficit
-$208M
(19.07%↑ Y/Y)
Additional paid-in capital
$155M
(53.47%↑ Y/Y)
Total liabilities
$1,441M
(-15.68%↓ Y/Y)
Total current
liabilities
$868M
(-17.80%↓ Y/Y)
Long-term debt, less
current portion
$487M
(58.12%↑ Y/Y)
Accrued litigation
settlement expenses,...
$42M
(-85.95%↓ Y/Y)
Other noncurrent
liabilities
$31M
(72.22%↑ Y/Y)
Operating lease
liabilities, noncurrent
$13M
(-55.17%↓ Y/Y)
Accrued rebates and
product returns
$610M
(-13.96%↓ Y/Y)
Accounts payable and
accrued expenses
$206M
(5.10%↑ Y/Y)
Income taxes payable
$30M
(76.47%↑ Y/Y)
Accrued litigation
settlement expenses,...
$14M
(-86.67%↓ Y/Y)
Operating lease
liabilities, current
$9M
(-18.18%↓ Y/Y)
Buy us a coffee
indivior-logo-svg
Indivior Pharmaceuticals, Inc. (INDV)
indivior-logo-svg
Indivior Pharmaceuticals, Inc. (INDV)